SANGAMO THERAPEUTICS ($SGMO) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$0.08 per share, missing estimates of $0.01 by $0.09. The company also reported revenue of $1,440,000, missing estimates of $34,399,500 by $-32,959,500.
You can see Quiver Quantitative's $SGMO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SANGAMO THERAPEUTICS Insider Trading Activity
SANGAMO THERAPEUTICS insiders have traded $SGMO stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $SGMO stock by insiders over the last 6 months:
- NATHALIE DUBOIS-STRINGFELLOW (SVP-CHIEF DEVELOPMENT OFFICER) sold 345,942 shares for an estimated $89,183
- GREGORY D DAVIS (Head of Research & Technology) sold 69,827 shares for an estimated $17,694
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
SANGAMO THERAPEUTICS Hedge Fund Activity
We have seen 44 institutional investors add shares of SANGAMO THERAPEUTICS stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GSA CAPITAL PARTNERS LLP removed 3,584,330 shares (-97.9%) from their portfolio in Q4 2025, for an estimated $1,505,418
- JANE STREET GROUP, LLC removed 2,918,127 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $720,485
- TWO SIGMA INVESTMENTS, LP added 2,276,809 shares (+91.8%) to their portfolio in Q4 2025, for an estimated $956,259
- TWO SIGMA ADVISERS, LP added 2,234,900 shares (+106.0%) to their portfolio in Q4 2025, for an estimated $938,658
- RENAISSANCE TECHNOLOGIES LLC removed 1,752,140 shares (-17.2%) from their portfolio in Q4 2025, for an estimated $735,898
- UBS GROUP AG added 1,546,517 shares (+151.0%) to their portfolio in Q1 2026, for an estimated $381,835
- WASATCH ADVISORS LP removed 1,416,717 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $349,787
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
